8 authorised products containing Sitagliptin phosphate monohydrate, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Januvia 100 mg film-coated tablets EU/1/07/383/13-18 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Januvia 25 mg film-coated tablets EU/1/07/383/1-6 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV, | — |
| Januvia 50 mg film-coated tablets EU/1/07/383/7-12 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Steglujan 15 mg/100 mg film-coated tablets EU/1/18/1266/007-012 |
Ertugliflozin l-pyroglutamic acid, Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Steglujan 5 mg/100 mg film-coated tablets EU/1/18/1266/001-006 |
Ertugliflozin l-pyroglutamic acid, Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Xelevia 100 mg film-coated tablets EU/1/07/382/13-18 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Xelevia 25 mg film-coated tablets EU/1/07/382/1-6 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Xelevia 50 mg film-coated tablets EU/1/07/382/7-12 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.